Haofei Yu

729 total citations
51 papers, 508 citations indexed

About

Haofei Yu is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, Haofei Yu has authored 51 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 16 papers in Molecular Biology and 14 papers in Biochemistry. Recurrent topics in Haofei Yu's work include Alkaloids: synthesis and pharmacology (27 papers), Traditional and Medicinal Uses of Annonaceae (14 papers) and Natural product bioactivities and synthesis (9 papers). Haofei Yu is often cited by papers focused on Alkaloids: synthesis and pharmacology (27 papers), Traditional and Medicinal Uses of Annonaceae (14 papers) and Natural product bioactivities and synthesis (9 papers). Haofei Yu collaborates with scholars based in China, Pakistan and United States. Haofei Yu's co-authors include Xiao‐Dong Luo, Caifeng Ding, Yaping Liu, Xin Wei, Xu‐Jie Qin, Rongping Zhang, Lanchun Zhang, Jing Yang, Zhi Dai and Afsar Khan and has published in prestigious journals such as Scientific Reports, The Journal of Organic Chemistry and Molecules.

In The Last Decade

Haofei Yu

47 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haofei Yu China 13 249 190 129 118 113 51 508
Laura Flores‐Bocanegra United States 12 234 0.9× 186 1.0× 145 1.1× 169 1.4× 70 0.6× 25 561
Kazumasa Zaima Japan 15 309 1.2× 324 1.7× 120 0.9× 250 2.1× 134 1.2× 35 715
Guanqun Zhan China 18 236 0.9× 359 1.9× 160 1.2× 236 2.0× 167 1.5× 35 699
Dong-Bo Zhang China 13 170 0.7× 248 1.3× 100 0.8× 139 1.2× 93 0.8× 28 523
Mohd Azlan Nafiah Malaysia 13 119 0.5× 196 1.0× 74 0.6× 127 1.1× 163 1.4× 66 477
Yumi Nishiyama Japan 17 172 0.7× 266 1.4× 180 1.4× 150 1.3× 186 1.6× 47 706
Mat Ropi Mukhtar Malaysia 16 231 0.9× 354 1.9× 91 0.7× 185 1.6× 155 1.4× 50 699
Momoyo Ichimaru Japan 17 142 0.6× 272 1.4× 153 1.2× 138 1.2× 187 1.7× 40 654
Ih‐Sheng Chen Taiwan 16 79 0.3× 272 1.4× 92 0.7× 92 0.8× 180 1.6× 31 495
V. Rama Subba Rao India 11 119 0.5× 163 0.9× 57 0.4× 121 1.0× 98 0.9× 21 389

Countries citing papers authored by Haofei Yu

Since Specialization
Citations

This map shows the geographic impact of Haofei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haofei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haofei Yu more than expected).

Fields of papers citing papers by Haofei Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haofei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haofei Yu. The network helps show where Haofei Yu may publish in the future.

Co-authorship network of co-authors of Haofei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Haofei Yu. A scholar is included among the top collaborators of Haofei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haofei Yu. Haofei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Haofei, Zhi Dai, Lanchun Zhang, et al.. (2025). Four Alkaloids from Alstonia scholaris with Antitumor Activity via Disturbing Glutathione Homeostasis. The Journal of Organic Chemistry. 90(3). 1280–1287. 1 indexed citations
2.
Zhang, Yuxiao, et al.. (2025). Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications. Frontiers in Cellular Neuroscience. 19. 1538026–1538026.
3.
Lin, Hua, et al.. (2025). Two novel iboga alkaloids with neuroprotective effects from Tabernaemontana corymbosa. Journal of Molecular Structure. 1335. 141973–141973. 1 indexed citations
4.
Hu, Jianlin, et al.. (2024). Chemical constituents from the pericarps of Zanthoxylum bungeanum Maxim. and their chemotaxonomic significance. Biochemical Systematics and Ecology. 119. 104941–104941. 1 indexed citations
5.
Yu, Haofei, et al.. (2024). MMoE: Enhancing Multimodal Models with Mixtures of Multimodal Interaction Experts. 10006–10030. 1 indexed citations
6.
Wang, Ruiyi, Haofei Yu, Wenxin Zhang, et al.. (2024). SOTOPIA-π: Interactive Learning of Socially Intelligent Language Agents. 12912–12940. 1 indexed citations
8.
Yu, Haofei, Lanchun Zhang, Zhi Dai, et al.. (2024). Alstoscholarisine L, a novel caged monoterpenoid indole alkaloid with antifungal activity from Alstonia scholaris. Fitoterapia. 180. 106341–106341. 2 indexed citations
9.
Yu, Haofei, Cunxiang Wang, Yue Zhang, & Wei Bi. (2023). TRAMS: Training-free Memory Selection for Long-range Language Modeling. 4966–4972.
10.
Wang, Chen, et al.. (2023). Research on the integral forming process of thin walled and thick mouth seamless gas cylinders. Scientific Reports. 13(1). 17021–17021. 2 indexed citations
11.
Ding, Caifeng, Jingzhi Zhao, Lanchun Zhang, et al.. (2023). Chemical constituents from the pericarps of Zanthoxylum bungeanum Maxim. and their chemotaxonomic significance. Biochemical Systematics and Ecology. 109. 104673–104673. 2 indexed citations
12.
Wei, Xin, Liyan Zhang, Wei Zhang, et al.. (2021). New oxindole alkaloids with selective osteoclast inhibitory activity from Gelsemium elegans. Natural Product Research. 36(10). 2630–2636. 9 indexed citations
13.
Song, Liu‐Dong, et al.. (2021). Synthesis of pterodontic acid derivatives and the study of their anti-influenza A virus (H1N1) activity. Fitoterapia. 152. 104942–104942. 5 indexed citations
14.
Zhang, Rongping, et al.. (2020). Partial Synthesis of Crassicauline A from Yunaconitine. Natural Products and Bioprospecting. 10(2). 105–108. 7 indexed citations
15.
Zhao, Yun‐Li, Xu‐Jie Qin, Yaping Liu, et al.. (2020). Anti-inflammatory and analgesic activities of Neolamarckia cadamba and its bioactive monoterpenoid indole alkaloids. Journal of Ethnopharmacology. 260. 113103–113103. 22 indexed citations
16.
He, Zhiyong, Ming Zhang, Lanchun Zhang, et al.. (2020). Resina Draconis Reduces Acute Liver Injury and Promotes Liver Regeneration after 2/3 Partial Hepatectomy in Mice. Evidence-based Complementary and Alternative Medicine. 2020(1). 2305784–2305784. 6 indexed citations
17.
Wei, Xin, Afsar Khan, Zhi Dai, et al.. (2017). Three New Pyridine Alkaloids from Vinca major Cultivated in Pakistan. Natural Products and Bioprospecting. 7(4). 323–327. 7 indexed citations
18.
Wei, Xin, Liping Jiang, Afsar Khan, et al.. (2017). Indole Alkaloids Inhibiting Neural Stem Cell from Uncaria rhynchophylla. Natural Products and Bioprospecting. 7(5). 413–419. 22 indexed citations
19.
Wang, Bei, Zhi Dai, Lu Liu, et al.. (2016). Indole Glycosides from Aqueous Fraction of Strychnos nitida. Natural Products and Bioprospecting. 6(6). 285–290. 7 indexed citations
20.
Bai, Rui, et al.. (2011). Modeling and simulation of the strip tension in bridle roll of the continuous annealing line. Chinese Control Conference. 1510–1514. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026